Non-interventional study on the effectiveness and safety of Empagliflozin compared with DPP-4 inhibitors in patients with type 2 diabetes in the United States First published 13/09/2017 Last updated 02/04/2024 EU PAS number:EUPAS20677 Study Ongoing